MedicinePsychology
DOI: 10.2174/1745017901006010001

tlooto Summary

An increase tolerability, a rapid response to therapy and an early onset of antidepressant fluvoxamine activity when associated with amisulpride in patients with major depressive disorder are observed.

Abstract

The topic of early response to antidepressant treatment has been extensively studied in major depressive disorder (MDD). We serendipitous observed an increase tolerability, a rapid response to therapy and an early onset of antidepressant fluvoxamine activity when associated with amisulpride in patients with major depressive disorder. The purpose of this study was to investigate our preliminary observations.

Citation format

HARDOY, M.; CARTA, M. Strategy to accelerate or augment the antidepressant response and for an early onset of SSRI activity. adjunctive amisulpride to fluvoxamine in major depressive disorder. Clinical Practice and Epidemiology in Mental Health, 2010, 6: 1–3.